{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "R1441C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations within LRRK2 predispose humans to develop PD by disrupting the protein's function and regulation.",
          "judgment": "Yes",
          "reasoning": "The introduction explicitly states that ‘autosomal dominant missense mutations within the gene encoding for the LRRK2 (leucine-rich repeat protein kinase 2) predispose humans to develop PD [1,2]’."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the impact of protein phosphorylation on LRRK2 interaction with 14-3-3, a known regulator, using an assay that assesses protein phosphorylation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly describes the assay used – phosphorylation analysis – as a core element in understanding LRRK2 regulation.",
          "next_step_or_outcome": "Proceed to Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "Based on the findings that five of six common pathogenic mutations display reduced phosphorylation of Ser 910/Ser 935, disrupting 14-3-3 binding, and accumulation within cytoplasmic pools, a PS3 designation is appropriate."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "R1441G",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations within LRRK2 predispose humans to develop PD by disrupting the protein's function and regulation.",
          "judgment": "Yes",
          "reasoning": "The introduction explicitly states that ‘autosomal dominant missense mutations within the gene encoding for the LRRK2 (leucine-rich repeat protein kinase 2) predispose humans to develop PD [1,2]’."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the impact of protein phosphorylation on LRRK2 interaction with 14-3-3, a known regulator, using an assay that assesses protein phosphorylation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly describes the assay used – phosphorylation analysis – as a core element in understanding LRRK2 regulation.",
          "next_step_or_outcome": "Proceed to Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "Based on the findings that five of six common pathogenic mutations display reduced phosphorylation of Ser 910/Ser 935, disrupting 14-3-3 binding and accumulation within cytoplasmic pools, a PS3 designation is appropriate."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "R1441H",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441H"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations within LRRK2 predispose humans to develop PD by disrupting the protein's function and regulation.",
          "judgment": "Yes",
          "reasoning": "The introduction explicitly states that ‘autosomal dominant missense mutations within the gene encoding for the LRRK2 (leucine-rich repeat protein kinase 2) predispose humans to develop PD [1,2]’."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the impact of protein phosphorylation on LRRK2 interaction with 14-3-3, a known regulator, using an assay that assesses protein phosphorylation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly describes the assay used – phosphorylation analysis – as a core element in understanding LRRK2 regulation.",
          "next_step_or_outcome": "Proceed to Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "Based on the findings that five of six common pathogenic mutations display reduced phosphorylation of Ser 910/Ser 935, disrupting 14-3-3 binding and accumulation within cytoplasmic pools, a PS3 designation is appropriate."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "R1441S",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations within LRRK2 predispose humans to develop PD by disrupting the protein's function and regulation.",
          "judgment": "Yes",
          "reasoning": "The introduction explicitly states that ‘autosomal dominant missense mutations within the gene encoding for the LRRK2 (leucine-rich repeat protein kinase 2) predispose humans to develop PD [1,2]’."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the impact of protein phosphorylation on LRRK2 interaction with 14-3-3, a known regulator, using an assay that assesses protein phosphorylation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly describes the assay used – phosphorylation analysis – as a core element in understanding LRRK2 regulation.",
          "next_step_or_outcome": "Proceed to Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "Based on the findings that five of six common pathogenic mutations display reduced phosphorylation of Ser 910/Ser 935, disrupting 14-3-3 binding and accumulation within cytoplasmic pools, a PS3 designation is appropriate."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "R1441Y",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441Y"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations within LRRK2 predispose humans to develop PD by disrupting the protein's function and regulation.",
          "judgment": "Yes",
          "reasoning": "The introduction explicitly states that ‘autosomal dominant missense mutations within the gene encoding for the LRRK2 (leucine-rich repeat protein kinase 2) predispose humans to develop PD [1,2]’."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the impact of protein phosphorylation on LRRK2 interaction with 14-3-3, a known regulator, using an assay that assesses protein phosphorylation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly describes the assay used – phosphorylation analysis – as a core element in understanding LRRK2 regulation.",
          "next_step_or_outcome": "Proceed to Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "Based on the findings that five of six common pathogenic mutations display reduced phosphorylation of Ser 910/Ser 935, disrupting 14-3-3 binding and accumulation within cytoplasmic pools, a PS3 designation is appropriate."
    }
  ]
}